Association between smoking status and homocysteine levels and possible effect modification by cholesterol and oestradiol

Abstract Introduction: This study aimed to examine the association of smoking status with homocysteine levels and to determine whether the association is modified by oestradiol or cholesterol. Methods: Data (N = 4580) were obtained from National Health and Nutrition Examination Survey 2003–2004 with analysis done in 2018 on adults aged ≥20 years. The outcome was homocysteine; smoking status was the exposure variable and categorized as current, former or never smoker. Generalized linear models were used to examine the associations between smoking status and homocysteine levels, while assessing the impact of oestradiol and cholesterol. Results: After adjusting for age, sex, ethnicity, education and income level, homocysteine levels did differ by smoking status ((current smokers versus never smokers: β: 0.18 CI: 0.00, 0.36), (former smokers: β: 0.10 CI: –0.09, 0.28)). The addition of oestradiol as an interaction term in adjusted models was associated with a 16.6% increase in homocysteine levels when compared to models without the interaction term. Oestradiol but not cholesterol did moderate the association between smoking status and homocysteine levels. Discussion and conclusions: Homocysteine levels did differ across smoking status after adjusting for confounders. Oestradiol did moderate the relationship between homocysteine and smoking status.

[1]  F. Fan,et al.  Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population , 2017, Lipids in Health and Disease.

[2]  J-R Zhang,et al.  Effects of blood lead and cadmium levels on homocysteine level in plasma. , 2017, European review for medical and pharmacological sciences.

[3]  Xiping Xu,et al.  Elevation in Total Homocysteine Levels in Chinese Patients With Essential Hypertension Treated With Antihypertensive Benazepril , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[4]  R. Kinscherf,et al.  Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status. , 2015, The American journal of clinical nutrition.

[5]  Yuemin Sun,et al.  Association of cardiometabolic risk profile with prehypertension accompany hyperhomocysteinaemia , 2015, Clinical and experimental hypertension.

[6]  J. Pizzorno Homocysteine: Friend or Foe? , 2014, Integrative medicine.

[7]  A. Georgiades,et al.  Changes in Body Composition Predict Homocysteine Changes and Hyperhomocysteinemia in Korea , 2013, Journal of Korean medical science.

[8]  M. Najjar,et al.  Effect of cigarette smoking on plasma homocysteine concentrations , 2011, Clinical chemistry and laboratory medicine.

[9]  J. H. Lee,et al.  Associations of plasma homocysteine level with brachial-ankle pulse wave velocity, LDL atherogenicity, and inflammation profile in healthy men. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  Megan E. Piper,et al.  Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. , 2011, American heart journal.

[11]  K. Seung,et al.  Passive smoking in never-smokers is associated with increased plasma homocysteine levels. , 2010, International heart journal.

[12]  M. K. Kim,et al.  Major Determinants of Serum Homocysteine Concentrations in a Korean Population , 2010, Journal of Korean medical science.

[13]  S. Arora,et al.  Homocysteine and lipoprotein (a) correlation in ischemic stroke patients , 2009, Journal of the Neurological Sciences.

[14]  A. Fitzgerald,et al.  Homocysteine increases the risk associated with hyperlipidaemia , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[15]  K. Pawlicki,et al.  The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers , 2004, Clinical chemistry and laboratory medicine.

[16]  Michael T. Molla,et al.  Summary measures of population health: Report of findings on methodologic and data issues , 2003 .